OC-02 Gemcitabine with or without prophylactic weight-adjusted dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)

✍ Scribed by A. Maraveyas; J. Waters; R. Roy; D. Propper; D. Fyfe; F. Lofts; G. Bozas; E. Gardiner; J. Sgouros; K.R. Wedgewood

• Book ID: 117258195
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 88 KB
• Volume: 125
• Category: Article
• ISSN: 0049-3848
• DOI: 10.1016/s0049-3848(10)70037-2